
Michael
M&A, Investment, Fundraising
Amsterdam, Netherlands
Leveraging extensive project experience across M&A, strategy consulting, and investing, I excel in managing transaction processes, crafting effective strategic narratives, and assessing investment opportunities. I am dedicated to guiding entrepreneurs and investors to successful transactions. I provide tailored services including: - Sell-side M&A advisor for SMEs - Commercial due diligence for PE/VC - Fundraising advisor for startups/scale-ups Specialization: Venture Capital; Fundraising; Private Equity; M&A; Commercial Due Diligence; Deal Valuation
Domain experience
Relevant Total Experience: 8 years
Seniority Level: Senior
Sector Experience:
Banks Diversified Financials Household Durables Insurance Pharmaceuticals, Biotechnology and Life Sciences Software and ServicesSkills
Skilled in: Corporate Strategy, Divestitures, Venture and minority investments, Commercial Due Diligence, Vendor Due Diligence, Term Sheet, Bolt-on acquisitions, Buy-and-Build, Value Creation & Enhancement, Private Equity & Growth Capital, Sell-side M&A, Corporate Development, Buy-Side M&A
Technical Skills: Microsoft Excel, PowerPoint, Microsoft Office, Capital IQ, Python
Languages: English, Chinese (Mandarin)
Work Experience
Surmount Ventures
Investment Manager
●01/03/2021
- 1/3/2024
- Directed the sell-side execution of a platform investment (encompassing 4x biotech portfolio companies), securing 4x LOIs from mid-to-large cap private equity investors. Key responsibilities included exit readiness preparation, equity story and Information Memorandum, drafting Q&A replies, management session coordination, and deal structure / fund flow evaluation - Conducted initial evaluation, led pitch sessions of all opportunities of the venture / growth fund in Health & Technology - Synthesized IC memorandums; performed commercial & financial due diligence and managed legal & IP DD advisors - Defined transaction structures and managed legal closing processes in Dutch, UK, and US jurisdictions - Closed 3x investments at Seed and Series A stages in Biotech and Deeptech - Initiated and spearheaded the investment thesis development of early-stage investments in AI and TechBio / Digital Health
HHV Biotech
Venture Builder - Corporate Development
●1/3/2021
- 1/2/2022
- Launched Surmount’s venture studio infectious diseases biotech company, as a core member of the two-person founding team, and grew the company from a research concept with a lead compound to a preclinical stage entity within the first year - Identified and prioritized top-3 medical indications based on market, clinical development, and route of administration - Collaborated with expert advisors on mapping out the full preclinical drug development plan - Developed a scenario-based financial planning / cash flow model based on a series of go / no-go decision points - Interviewed panels of key opinion leaders and initiated academic partnerships - Selected CROs / CDMOs and coordinated interdependent development activities across multiple external research sites
Strategy&, part of the PwC network
Manager - M&A Deals
●01/10/2020
- 01/02/2021
- Led 20+ commercial due diligence and validated all strategic aspects of private equity investments, including market size / segmentation, competitive position, value chain, synergy potential, business plan achievability and value creation levers - Formulated growth / market entry strategies alongside private equity portfolio companies’ C-level executive teams - Developed equity stories and IM for mid-market deals with a focus on financial services and technology - Mapped the Benelux Fintech landscape and advised financial institutions to develop their Fintech investment strategies
Strategy&, part of the PwC network
Senior Associate - M&A Deals
●01/09/2018
- 01/09/2020
- Corporate finance: Buy side and sell side deal origination and execution with a focus on cross-border mid-market transactions - Valuation: Financial modeling using various methods, including DCF, LBO, Multiples, with a focus on financial services - Commercial due diligence: Market sizing, expert interviews, and business plan assessments - Financial due diligence: Quality of earnings, EV to equity bridge (net debt, net working capital)
PwC
M&A Deals Associate
●01/09/2016
- 01/08/2018
Oliver Wyman
Summer Management Consultant
●01/06/2015
- 01/08/2015
- Managed the PMO for the Asset Liability Management division of a top-3 Dutch bank as part of the bank’s broader IPO process
Berkeley SkyDeck
Financial Planning Intern
●01/11/2014
- 01/01/2015
- Built a five-year financial plan for an Automated Speech Recognition startup – Remeeting
Education
CFA Institute
Investment Management
●01/12/2017
- 01/06/2019
- Charterholder since 06/2020 and passed all three levels above the 90th percentile worldwide on the first attempt
Rotterdam School of Management, Erasmus University
Finance and Investments
●01/09/2015
- 01/07/2016
- GPA: 4.0/4.0; GMAT: 740/800; NL Grade: 8.5/10/0 - Full scholarship; Cum Laude; Honors Program - Top 2% in courses including corporate finance, investments, and advanced valuation - Organizer of the International Business Project (Tel Aviv); Rotterdam Consulting Club
Haas School of Business, University of California, Berkeley
Business Administration
●01/08/2014
- 01/12/2014
- GPA: 3.9/4.0
Utrecht University
Economics and Business Economics
●01/09/2012
- 01/07/2015
- GPA: 4.0/4.0; NL Grade: 8.9/10.0 - Ranked No. 1 among a cohort of more than 300 students; Cum Laude; Honors Program - Investment Committee
Licenses / Certificates
CFA Institute
Chartered Financial Analyst (CFA)
●30/08/2021
Stanford University
Machine Learning Specialization
Want to work with Michael?
Sign up on the Fintalent platform to get in touch with Michael and 2,500+ other M&A freelancers!